BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28549241)

  • 21. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
    Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
    J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The assessment of chosen psychometric features of B-CATS test battery in schizophrenia - preliminary report].
    Jędrasik-Styła M; Ciołkiewicz A; Styła R; Pankowski D; Denisiuk M; Linke M; Jarema M; Wichniak A
    Psychiatr Pol; 2014; 48(6):1189-200. PubMed ID: 25717488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using the Brief Assessment of Cognition in Schizophrenia (BACS) to assess cognitive impairment in older patients with schizophrenia and bipolar disorder.
    Cholet J; Sauvaget A; Vanelle JM; Hommet C; Mondon K; Mamet JP; Camus V
    Bipolar Disord; 2014 May; 16(3):326-36. PubMed ID: 24383665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance on the Cognitive Estimation Test in schizophrenia.
    Roth RM; Pixley HS; Kruck CL; Garlinghouse MA; Giancola PR; Flashman LA
    Appl Neuropsychol Adult; 2012; 19(2):141-6. PubMed ID: 23373582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the Montreal Cognitive Assessment (MoCA) as a cognitive screener in severe mental illness.
    Musso MW; Cohen AS; Auster TL; McGovern JE
    Psychiatry Res; 2014 Dec; 220(1-2):664-8. PubMed ID: 25150920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An optimal combination of MCCB and CANTAB to assess functional capacity in older individuals with schizophrenia.
    Kumar S; Mulsant BH; Tsoutsoulas C; Ghazala Z; Voineskos AN; Bowie CR; Rajji TK
    Int J Geriatr Psychiatry; 2016 Oct; 31(10):1116-23. PubMed ID: 27428251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Chinese Version of the Brief Assessment of Cognition in Schizophrenia: Data of a Large-Scale Mandarin-Speaking Population.
    Wang LJ; Huang YC; Hung CF; Chen CK; Chen YC; Lee PY; Wang SM; Liu MH; Lin CJ; Hsu ST
    Arch Clin Neuropsychol; 2017 May; 32(3):289-296. PubMed ID: 28431029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Brazilian standardization of the MATRICS consensus cognitive battery (MCCB): Psychometric study.
    Fonseca AO; Berberian AA; de Meneses-Gaya C; Gadelha A; Vicente MO; Nuechterlein KH; Bressan RA; Lacerda ALT
    Schizophr Res; 2017 Jul; 185():148-153. PubMed ID: 28110814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.
    Keefe RS; Goldberg TE; Harvey PD; Gold JM; Poe MP; Coughenour L
    Schizophr Res; 2004 Jun; 68(2-3):283-97. PubMed ID: 15099610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between neuropsychological and social cognition measures and symptom dimensions in schizophrenic patients.
    Altamura AC; Caletti E; Paoli RA; Cigliobianco M; Zugno E; Grillo P; Prunas C; Caldiroli A; Zago S
    Psychiatry Res; 2015 Dec; 230(2):172-80. PubMed ID: 26350702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Cognitive Screening Scale for Schizophrenia (CSSS) - Part 2: Validity of the Scale.
    Mosiołek A; Gierus J; Koweszko T; Nowakowska A; Szulc A
    Psychiatr Pol; 2018 Apr; 52(2):241-250. PubMed ID: 29975364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychological correlates of cognitive insight in schizophrenia.
    Orfei MD; Spoletini I; Banfi G; Caltagirone C; Spalletta G
    Psychiatry Res; 2010 Jun; 178(1):51-6. PubMed ID: 20452049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia.
    Pino O; Guilera G; Rojo JE; Gómez-Benito J; Bernardo M; Crespo-Facorro B; Cuesta MJ; Franco M; Martinez-Aran A; Segarra N; Tabarés-Seisdedos R; Vieta E; Purdon SE; Díez T; Rejas J;
    Schizophr Res; 2008 Feb; 99(1-3):139-48. PubMed ID: 17959358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-cultural adaptation and validation of the Arabic version of the BACS scale (the brief assessment of cognition in schizophrenia) among chronic schizophrenic inpatients.
    Haddad C; Salameh P; Hallit S; Obeid S; Haddad G; Clément JP; Calvet B
    BMC Psychiatry; 2021 May; 21(1):223. PubMed ID: 33933025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia).
    Araújo GE; Resende CB; Cardoso AC; Teixeira AL; Keefe RS; Salgado JV
    Clinics (Sao Paulo); 2015 Apr; 70(4):278-82. PubMed ID: 26017795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
    Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
    J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Social dysfunction in schizophrenia: an investigation of the GAF scale's sensitivity to deficits in social cognition.
    Robertson DA; Hargreaves A; Kelleher EB; Morris D; Gill M; Corvin A; Donohoe G
    Schizophr Res; 2013 May; 146(1-3):363-5. PubMed ID: 23422729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia.
    Mazhari S; Ghafaree-Nejad AR; Soleymani-Zade S; Keefe RSE
    Asian J Psychiatr; 2017 Jun; 27():12-15. PubMed ID: 28558882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of learning potential in cognitive remediation: Construct and predictive validity.
    Davidson CA; Johannesen JK; Fiszdon JM
    Schizophr Res; 2016 Mar; 171(1-3):117-24. PubMed ID: 26833267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor analytic support for social cognition as a separable cognitive domain in schizophrenia.
    Allen DN; Strauss GP; Donohue B; van Kammen DP
    Schizophr Res; 2007 Jul; 93(1-3):325-33. PubMed ID: 17498927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.